04
Nov
Nov
Focal segmental glomerulosclerosis (FSGS) is a rare kidney disorder that affects children and adults, and might result in kidney failure. Latest findings from a team led by the University of Minnesota Medical School show patients with FSGS who were treated with the medication sparsentan experienced improved kidney function-; making it a possible recent treatment option […]